Column GROUP L P, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 145,166 shares at $17.99 ($2.6M) on 2020-07-27, disclosed to the SEC on 2020-07-28.
Open-market purchase of $2.6M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.93 | 68,749 | $1.2M | 47.4% |
| 2 | $17.93 | 68,749 | $1.2M | 47.4% |
| 3 | $17.99 | 3,834 | $69K | 2.6% |
| 4 | $17.99 | 3,834 | $69K | 2.6% |
| Total | $17.93 avg | 145,166 | $2.6M | 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |